NewLink Genetics (NLNK) Reports Q2 Loss of $0.57/Share

NewLink Genetics (NASDAQ: NLNK) reported Q2 EPS of ($0.57), versus ($1.12) reported last year. Revenue for the quarter came in at $10.4 million, versus $2.01 million reported last year.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• KeyBanc Upgrades Acadia Realty Trust (AKR) to Overweight